87
Participants
Start Date
April 20, 2016
Primary Completion Date
December 31, 2023
Study Completion Date
February 13, 2026
Biospecimen Collection
Undergo blood sample collection
Bone Marrow Aspiration
Undergo bone marrow biopsy and aspiration
Bone Marrow Biopsy
Undergo bone marrow biopsy and aspiration
Chemotherapy
Given anthracycline IV
Computed Tomography
Undergo FLT PET/CT
Cytarabine
Given IV
Fluorothymidine F-18
Undergo FLT PET/CT
Laboratory Biomarker Analysis
Correlative studies
Positron Emission Tomography
Undergo FLT PET/CT
Mount Sinai Hospital, New York
University of Pennsylvania/Abramson Cancer Center, Philadelphia
Fox Chase Cancer Center, Philadelphia
UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Vanderbilt University/Ingram Cancer Center, Nashville
University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Mayo Clinic in Rochester, Rochester
Washington University School of Medicine, St Louis
University of Oklahoma Health Sciences Center, Oklahoma City
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Huntsman Cancer Institute/University of Utah, Salt Lake City
National Cancer Institute (NCI)
NIH